Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E Harrison
Ventricular Arrhythmias During Treatment With Alteplase (Recombinant Tissue Plasminogen Activator) in Suspected Acute Myocardial Infarction.
Heart
Cardiovascular Medicine
Cardiology
Related publications
TNK Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction : Results of the TIMI 10B Trial
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Dose Ranging Study of Tissue Plasminogen Activator in Acute Myocardial Infarction.
BMJ
Dose Ranging Study of Tissue Plasminogen Activator in Acute Myocardial Infarction: Authors' Reply
BMJ
Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke Can Cause Inferior Myocardial Infarction?
Neurology International
Neurology
Incidence and Management of Ventricular Arrhythmias After Acute Myocardial Infarction.
Heart
Cardiovascular Medicine
Cardiology
Massive Pulmonary Embolism During Pregnancy Successfully Treated With Recombinant Tissue Plasminogen Activator
Archives of Internal Medicine
Effect of Thrombolysis on Myocardial Injury: Recombinant Tissue Plasminogen Activator vs. Alfimeprase
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
Intravenous and Intrapulmonary Recombinant Tissue-Type Plasminogen Activator in the Treatment of Acute Massive Pulmonary Embolism
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Cardiac Arrhythmias During Myocardial Infarction
Baylor University Medical Center Proceedings
Medicine